Global Herpes Simplex Virus Treatment Market Size By Drug (Acyclovir, Valacyclovir, Famciclovir), By End User (Hospital pharmacies, Retail pharmacies), By Geographic Scope And Forecast

Herpes Simplex Virus Treatment Market Size And Forecast

Herpes Simplex Virus Treatment Market size was valued at USD 2371.74 Million in 2022 and is projected to reach USD 3909.42 Million by 2030, growing at a CAGR of 5.71% from 2023 to 2030.

The expansion of Herpes Simplex Virus Treatment is being fuelled by an increase in the incidence of HSV infection, the incidence of new infections, and continual microorganism changes that result in new strains. An increase in the means of transmission of the infectious disease, as well as a lack of sanitation in emerging countries, are driving the market for herpes simplex virus infection therapy. Women are infected with HSV-2 at a higher incidence than men, according to the World Health Organization. As the prevalence of HSV encephalitis rises, the market for this industry is likely to develop.

Global Herpes Simplex Virus Treatment Market Definition

Sexually transmitted disease, commonly known as venereal disease, is an infection that is caught and transferred through sexual activity and transferred by body fluids such as sperm, vaginal fluid, or blood. Bacteria, parasites, yeast, and virus are the causative agents of STDs. Skin rashes, warts, intestinal aches, and vaginal ulcers are all symptoms of STDs. Physical examination or assays like ELISA (Enzyme-Linked Immunosorbent Assay), fast plasma, blood sample, or antibody-absorption blood test are used to identify STDs.The herpes simplex virus causes herpes (HSV). Herpes can affect any part of the body, although the genitals and mouth are the most commonly affected.

There are two forms of herpes simplex virusHSV-1 is primarily responsible for oral herpes, causing cold sores and fever blisters around the mouth and on the face. The virus that causes genital herpes and is responsible for the majority of outbreaks is HSV-2. According to the Centers for Disease Control and Prevention (CDC), HSV-2 was found in over 16 percent of the US population, with African-American women being the most affected. HSV-1 has only a few occurrences of genital herpes (infections in the genital or anal area). HSV-2 is the most prevalent sexually transmitted infection that infects genital herpes (GH) as well as being the most contagious.

HSV-2 infection can be both chronic and fatal. Patients with HSV-2 are more likely to be infected with the human immunodeficiency virus (HIV). The likelihood of HSV-1 recurrence is lower than those of HSV-2. According to the Canadian Public Health Agency, the prevalence of HSV-1 infection is greater than those of HSV-2 infection in most locations. According to numerous sources, HSV incidence is also increased in low- and middle-income regions. Approximately 80% of herpes outbreaks are silent. Asymptomatic infection is characterized by blistering sores, discomfort while urination, swelling lymphatic system, and fever. The latency time and mode of reactivation of HSV are unknown.

Global Herpes Simplex Virus Treatment Market Overview

An increase in the incidence of HSV infection, an increase in the incidence of new infections, and continual microorganism changes that result in new strains are driving the global Herpes Simplex Virus Treatment Market. Furthermore, growth in the means of transmission of contagious diseases and a lack of sanitation in emerging countries are fueling the market growth for herpes simplex virus infection therapy. Women are infected with HSV-2 at a higher incidence than men, according to the World Health Organization.

As the prevalence of HSV encephalitis rises, the market for this industry is likely to develop. In addition to increasing research and development activity, the market is growing. The Herpes Simplex Virus Treatment Market has a lot of potential because of the massive burden of HSV infectious diseases on healthcare systems across the globe, which is driving huge investments in research and development of effective therapeutics for infectious diseases, is expected to boost the market’s growth. Furthermore, acyclovir is in high demand around the world.

Increased prevalence of herpes encephalitis, increased demand for efficient treatment for rare conditions, ongoing microorganism changes leading to new virus strains, and increased mode of herpes transmission are some of the factors driving the growth of the Herpes Simplex Virus Treatment Market. The pandemic of COVID-19 has had a substantial impact on market growth. The researcher established the link between the herpes simplex virus and the SARS-CoV-2 virus in many studies, which influenced the market positively resulting in an increase in the demand for antiviral drugs for treatment. COVID-19 and its impact on people with HSV are also expected to drive growth.

However, high treatment costs and an increase in the incidence of herpes simplex virus encephalitis may stymie market expansion and pose new challenges to the Herpes Simplex Virus Treatment Market. The negative problems associated with drug use and a lack of knowledge about herpes therapy are limiting the market’s expansion. On the other hand, attractive reimbursement policies and government backing for board authorities present new opportunities in the business.

Global Herpes Simplex Virus Treatment Market Segmentation Analysis

The Global Herpes Simplex Virus Treatment Market is segmented on the basis of Drug, End User, And Geography.

Herpes Simplex Virus Treatment Market, By Drug

• Acyclovir
• Valacyclovir
• Famciclovir

Based on Drug, The market is bifurcated into Acyclovir, Valacyclovir, and Famciclovir. The Herpes Simplex Virus Treatment Market is dominated by acyclovir. The Herpes Simplex Virus Treatment Market is dominated by acyclovir. Antiviral medication acyclovir is often used to treat herpes. Oral herpes and HSV encephalopathy are treated with it. It’s a purine nucleoside analog that gets into viral DNA and transforms to acyclovir triphosphate, which stops the virus from reproducing. Furthermore, the increased prevalence of HSV encephalitis is expected to boost the market for this product. Acyclovir sales are estimated to reach $ 305.4 million in 2021, accounting for almost 30% of the global Market. The most often used antiviral for the therapy of HSV1 infections is acyclovir, which provides producers with a plethora of profitable ventures shortly.

Herpes Simplex Virus Treatment Market, By End User

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Based on End User, The market is bifurcated into Hospital pharmacies, Retail pharmacies, and Online pharmacies. The retail pharmacy segment held the greatest market share, which is expected to increase over the forecast period. The most common cause of genital herpes is an increase in the number of people who suffer from lifestyle-related disorders such as stress, sedentary lifestyles, poor eating habits, and an unsanitary routine. This will help the global Herpes Simplex Virus Treatment Market flourish by continuously managing drugs.

This will make prescription-based pharmaceuticals even more mandatory, boosting the global pharmacy retail economy. As a result, these factors are expected to propel the worldwide Herpes Simplex Virus Treatment Market forward throughout the forecast period. The internet pharmacy is also contributing to the growth, thanks to the Covid-19 outbreak and lockdowns around the world. Furthermore, the online pharmacy’s doorstep service is a significant contributor to industry growth.

Herpes Simplex Virus Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, The Herpes Simplex Virus Treatment Market is classified into North America, Europe, Asia Pacific, Rest of the world. North America is the dominant region for Herpes Simplex Virus Treatment in terms of market revenue. According to the American Sexual Health Association, around half of the population in the United States is infected with HSV-1, which causes oral herpes. Furthermore, HSV-2 infection affects about one out of every eight people. Furthermore, the National Institutes of Health estimates that by the age of 50, 90 percent of persons in the United States have been exposed to the virus. As a result, there is a demand for herpes treatment, which is projected to boost the Herpes Simplex Virus Treatment Market.

Key Players

The “Global Herpes Simplex Virus Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Agenus Inc, GlaxoSmithKline plc, Maruho Co Ltd, Merck & Co Inc, Sanofi Pasteur SA, Chimerix, Novartis AG, Apotex Inc, Admedus, Epi Health LLC. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• United BioPharma teamed up with the Shanghai Public Health Clinical Centre and Cheng Kung University’s Department of Microbiology and Immunology in October 2021 to test the efficacy of UB-621, a best-in-class long-acting treatment for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).
• In July 2021, AiCuris Anti-infective Cures AG began Phase III testing of pritelivir, a novel helicase-primase inhibitor, in immunocompromised individuals with acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections.
• Clear Probiotics will release its Synbiotic with Lactobacillus Rhamnosus GG in 2020. (LGG). This substance can aid in the prevention and treatment of herpes outbreaks.
• Perrigo plans to release its AB-rated generic Zovirax cream in 2020. This medicine contains acyclovir, which can be used to prevent additional herpes issues.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.